Augmentation of SURF1 expression, bezafibrate treatment, or PGC1A induction increases mitochondrial biogenesis, reducing the pathological phenotypes and revealing a potential treatment for LS.28 The gene discussed is SURF1; the disease is Leigh syndrome.